Skip to content

GSK plc ADRhedged

GSKHNYSE ArcaADRhedgedC

$69.24−0.25 (−0.36%)

As of Nov 2, 2026, 12:06 PM ET

Intraday session: down, 27 prints from 69.49 to 69.24. Range 69.24 to 69.49. Use the arrow keys to read each point.69.3069.3569.4069.4510 AM12 PM2 PM4 PM
Expense ratio
0.19%
Fund size
$1M
1Y total return
+6.3%
Yield · Last 12 months
No data
Holdings
2
Avg volume · 30D
381 sh
52W range
low $65.65high $85.03
Launched
Filings
SEC EDGAR

The ETF.net GSKH Grade

Based on 5 of 6 pillars

C

Score 40 out of 100

Rank
4 of 9
Six-pillar profile for GSKH. Scores out of 100: Cost 59, Risk 49, Mission not scored, Tradability 40, Holdings 45, Durability 26. Strongest: Cost (59). Weakest: Durability (26). Based on 5 of 6 pillars.

Score 40 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

Very small fund, grade capped at C.

The cap holds the Score at 40 or below, so B and A are out of reach.

The pillars earned
49
This cap took
−9
Published Score
40 Grade C
  • Cost

    The fund’s net expense ratio, ranked against its category.
    B59 out of 100
    Rank 1 of 9
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    C49 out of 100
    Rank 5 of 9
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C40 out of 100
    Rank 6 of 9
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C45 out of 100
    Rank 5 of 8
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    D26 out of 100
    Rank 7 of 9

Our read on GSKH

ETF.net Research

In short

CGSK, minus the currency noise. A single-stock ADR wrapper on the UK pharma giant with the pound hedge built in, so what you own is the stock's move rather than the exchange rate's.

Stated mandate

The fund is an ADR-hedged ETF providing exposure to GSK plc, a global pharmaceutical and biotechnology company focused on vaccines.

Why people hold it

  • The currency hedge is built into the wrapper, so holding a UK-listed drugmaker stays a pharma call instead of doubling as a pound call.precidian.com
  • 0.19% a year, the same sticker carried across the ADRhedged lineup, for a hedge most individual investors cannot run cheaply themselves.
  • One US-listed ticker covers the ADR and the hedge together, with distributions on a quarterly cadence.

Worth knowing

  • Small and thinly traded, which usually means wider bid-ask spreads and more of the cost showing up in the trade itself.
  • One company, one story: GSK's pipeline, patents and litigation headlines drive the entire position, with no diversification to soften them.
  • A hedge works in both directions, stripping out pound gains along with pound losses, and the fund only launched in 2025, so its record is short.

GSKH Performance

Launched Jan 3, 2025

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
GSKH$10,633
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. GSKH $10,633. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000$12,000$13,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for GSKH. Periods over one year show the average yearly return.
PeriodGSKH
Year to date+3.7%
1 month+1.3%
3 months−3.0%
1 year+6.3%
3 yearsFund is under 3 years oldper yearNo data
5 yearsFund is under 5 years oldper yearNo data
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for GSKH
YearReturn barGSKH
2026 YTD+3.7%
2025+37.1%

History from Jan 7, 2025

GSKH in the news

GSKH Dividends

Last payment
$0.93 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution data unavailable.

Distribution history

2025–2026

One bar per payment. 3 payments from 2025 to 2026 YTD. Dec 16, 2025 $0.79; Mar 16, 2026 $0.36; Jun 16, 2026 $0.93. Use the arrow keys to read each point.20252026YTD
Ex-datePay dateAmount per share
Jun 16, 2026Jun 23, 2026$0.93
Mar 16, 2026Mar 23, 2026$0.36
Dec 16, 2025Dec 24, 2025$0.79

$10,000 in GSKH 1 year ago paid $309 in dividends.

GSKH Risk

How much the fund’s monthly returns vary, scaled to a year.
20.5%
Annualised · 21 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.78
vs 3-month T-bills · 21 months to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−21.1%
21 months · trough Oct 2026
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
−0.32
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

GSKH Cost

Tied cheapest in Currency-Hedged Funds

$3,952

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • GSKH 0.19%

    $3,952

$10,000
30 years

Cost over time

  • GSKH 0.19%
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$1K$2K$3K$4K051015202530GSKH $3,952

Year by year

YearGSKH
10$347
20$1,351
30$3,952

Other funds in Currency-Hedged Funds